Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sol Gel Technologies Ltd

4SG
Current price
0.4 EUR -0.048 EUR (-10.67%)
Last closed 0.49 USD
ISIN IL0011417206
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 18 664 596 USD
Yield for 12 month -63.30 %
1Y
3Y
5Y
10Y
15Y
4SG
21.11.2021 - 28.11.2021

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel. Address: 7 Golda Meir Street, Ness Ziona, Israel, 7403650

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5 USD

P/E ratio

Dividend Yield

Current Year

+1 554 000 USD

Last Year

+3 883 000 USD

Current Quarter

+5 433 000 USD

Last Quarter

+466 000 USD

Current Year

+1 212 000 USD

Last Year

-8 799 000 USD

Current Quarter

+2 995 000 USD

Last Quarter

-4 879 000 USD

Key Figures 4SG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -16 520 000 USD
Operating Margin TTM 29.89 %
PE Ratio
Return On Assets TTM -21.63 %
PEG Ratio
Return On Equity TTM -35.85 %
Wall Street Target Price 5 USD
Revenue TTM 6 559 000 USD
Book Value 1.25 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 814.6 %
Dividend Yield
Gross Profit TTM -8 799 000 USD
Earnings per share -0.54 USD
Diluted Eps TTM -0.54 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -227.4 %

Dividend Analytics 4SG

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 4SG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 4SG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 9.3371
Enterprise Value Revenue 0.1304
Price Sales TTM 2.8456
Enterprise Value EBITDA 0.2353
Price Book MRQ 0.5219

Financials 4SG

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 4SG

For 52 weeks

0.33 USD 1.59 USD
50 Day MA 0.65 USD
Shares Short Prior Month 82 928
200 Day MA 0.84 USD
Short Ratio 2.71
Shares Short 217 671
Short Percent 1.81 %